AzTrials
AzTrials

NeoplasmsNCT01255748

Registry Study for Radiation Therapy Outcomes

An observational study of Neoplasms, run by Proton Collaborative Group at 29 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy. Read more about this study

Who is it for?
Any age
Conditions the study is for
Neoplasms
What is being tested?
Proton Therapy, Photon Therapy, SRS, Brachytherapy
Type of treatment
Surgery or procedure
How many people
50,000 participants
Where
29 sitesUnited States
Study dates
Jun 2009to Jun 2039
How long will I take part?
30 Years
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Radiation Oncology patients

Who may be able to join

  • Planned treatment with radiation therapy
  • Ability to understand and sign IRB approved consent

Who cannot join

None listed.

Trial locations and contacts

29 sites in 1 country. Contact the study team or a site near you to ask about taking part.

29 sites in 1 country

United States29 sites, 29 recruiting

  • Emory Proton Therapy Center

    Atlanta, Georgia, 30308

    Leann Schilling, MPH, CCRP, 404-686-0286, leann.schilling@emory.edu

    Mark McDonald, MD

    Recruiting

  • Maryland Proton Treatment Center

    Baltimore, Maryland, 21201

    Caitlin Eggleston, 410-328-7586, caitlineggleston@umm.edu

    Mark Mishra, MD

    Recruiting

  • Atrium Health Levine Cancer Proton & Advanced Radiation Center

    Charlotte, North Carolina, 28204

    Maggie Dzhanumova, 980-515-5300, margarita.dzhanumova@atriumhealth.org

    Roshan Prabhu, MD

    Recruiting

  • University of Cincinnati Medical Center

    Cincinnati, Ohio, 45044

    Christine Vollmer, MBA, 513-213-3203, mccordce@ucmail.uc.edu

    Luke Pater, MD

    Recruiting

  • South Florida Proton Therapy Institute

    Delray Beach, Florida, 33484

    Salina Ramirez, 561-323-6360, sramirez@sfpti.com

    James Snider, MD

    Recruiting

  • Inova Schar Cancer Institute

    Fairfax, Virginia, 22031

    Sangeetha Moturi, 571-472-0343, sangeetha.moturi@inova.org

    Gopal Bajaj, MD

    Recruiting

  • McLaren Proton Therapy Center

    Flint, Michigan, 48532

    Drita Nuculovic, 810-342-5674, drita.nuculovic@mclaren.org

    Brian Yeh, MD

    Recruiting

  • Southwest Florida Proton Center

    Fort Myers, Florida, 33967

    Krisha Parikh, 239-516-0009, kparikh@swflproton.com

    Shannon MacDonald, MD

    Recruiting

  • Tennessee Oncology Proton Center

    Franklin, Tennessee, 37067

    Erick Vides, 615-716-4736, evides@tnonc.com

    James Gray, MD

    Recruiting

  • Hampton University Proton Therapy Institute

    Hampton, Virginia, 23666

    Donna Sternberg, RN, BSN, OCN, 757-251-6839, donna.sternberg@hamptonproton.org

    Christopher Sinesi, MD

    Recruiting

  • Texas Center for Proton Therapy

    Irving, Texas, 75063

    Vanetta Zollicoffer, 469-513-5531, vanetta.zollicoffer@usoncology.com

    Andrew Lee, MD

    Recruiting

  • Ackerman Cancer Center

    Jacksonville, Florida, 32223

    Mitchell Urmann, 904-880-5522, mitchellu@ackermancancer.com

    Ryan Perkins, MD

    Recruiting

  • University of Kansas Proton Therapy Center

    Kansas City, Kansas, 66160

    Amanda Schroeder, 913-588-1617, aschroeder3@kumc.edu

    Ronny Rotondo, MD

    Recruiting

  • Thompson Proton Center

    Knoxville, Tennessee, 37909

    Kristi Simcox, 865-331-4985, esimcox@covhlth.com

    Ryan Grover, MD

    Recruiting

  • Proton Center of Arkansas

    Little Rock, Arkansas, 72205

    Monica Coleman, 501-686-8274, mmcoleman@uams.edu

    Leslie Harrell, MD

    Recruiting

  • Dwoskin Proton Therapy Center

    Miami, Florida, 33125

    Felisa Flores, 305-243-4370, fflores2@med.miami.edu

    Matthew Abramowitz, MD

    Recruiting

  • Miami Cancer Institute

    Miami, Florida, 33176

    Michael Chuong, MD, 786-596-2000, michaelchu@baptisthealth.net

    Michael Chuong, MD

    Recruiting

  • New York Proton Center

    New York, New York, 10035

    Ryan Holder, 646-968-9055 ext. 387, rholder@nyproton.com

    Charles Simone, MD, FACRO

    Recruiting

  • Oklahoma Proton Center

    Oklahoma City, Oklahoma, 73142

    Angela Beebe, 405-773-6708, angela.beebe@okcproton.com

    John Chang, MD

    Recruiting

  • Orlando Health Cancer Institute

    Orlando, Florida, 32806

    Leila IP, BSN, RN, 321-843-3762, leila.ip@orlandohealth.com

    Naren Ramakrishna, MD, Ph. D

    Recruiting

  • Kansas City Proton Institute

    Overland Park, Kansas, 66207

    Judy Searcy, 913-647-4173, jsearcy@kcuc.com

    James Coster, MD

    Recruiting

  • OSF HealthCare Cancer Institute

    Peoria, Illinois, 61603

    Peyton Swearingen, 309-624-5013, peyton.o.swearingen@osfhealthcare.org

    Timothy Smile, MD

    Recruiting

  • California Protons Cancer Therapy Center

    San Diego, California, 92121

    Alexandra Crawford, MPH, 858-549-7431, alexandra.crawford@californiaprotons.com

    James Urbanic, MD

    Recruiting

  • Mayo Clinic

    Scottsdale, Arizona, 85259-5499

    Clinical Trials Office - All Mayo Clinic Locations, 855-776-0015 (toll free)

    Recruiting

  • University of Washington

    Seattle, Washington, 98195-6043

    Erica Peters, CCRC, CPM, 206-598-7188, etucker@uw.edu

    Annemarie Shepherd, MD

    Recruiting

  • Willis-Knighton Cancer and Proton Therapy Center

    Shreveport, Louisiana, 71103

    Briana Barrow, CCRC, 318-212-8671, bbarrow@wkhs.com

    Lane Rosen, MD

    Recruiting

  • ProCure Proton Therapy Center

    Somerset, New Jersey, 08873

    Heba Darwish, 732-357-2676, heba.darwish@nj.procure.com

    Henry Tsai, MD

    Recruiting

  • Mercy David C. Pratt Cancer Center

    St Louis, Missouri, 63141

    Nancy Umbeck, 314-251-7066, nancy.umbeck@mercy.net

    Amit Roy, MD

    Recruiting

  • Northwestern Medicine Chicago Proton Center

    Warrenville, Illinois, 60555

    Don Smith, MS, CCRC, 630-933-7820, donald.smith3@nm.org

    Arpi Thukral, MD

    Recruiting

Other trials in United States

About this study

Official title: Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Radiation Therapy

The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.

Conditions
Neoplasms
Being tested
Proton Therapy, Photon Therapy, SRS, Brachytherapy
Keywords
cancer, proton, radiation
Medical subject headings
Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Proton Therapy, Photon Therapy, SRS, BrachytherapyRadiation

    Outcomes Tracking

Study groups in NCT01255748
Study groupRoleWhat they receive
Treatment with Radiation TherapyIncludes 16 different arms to capture patient data by disease site
Receives: Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Define outcomes for patients treated at participating institutions

    Measured: PRN

Secondary outcomes (2)

  1. Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures

    Measured: Annually PRN

  2. Improve patient care by an adequate understanding of the results and patient population at participating institutions

    Measured: Reviewed Annually PRN

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Dec 2010 (estimated)
  2. Study startJun 2009
  3. Primary completionJun 2039 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50,000 participants (estimated)
Target duration
30 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT01255748
Sponsor's protocol ID
REG001-09
Status last verified
Sep 2026
First submitted
6 Dec 2010
Last updated
29 Sep 2026
Results posted
No
Data monitoring committee
No

Publications

  • Lee HJ Jr, Macomber MW, Spraker MB, Bowen SR, Hippe DS, Fung A, Russell KJ, Laramore GE, Rengan R, Liao J, Apisarnthanarax S, Zeng J. Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes. Radiat Oncol. 2018 Sep 17;13(1):179. doi: 10.1186/s13014-018-1127-6.

    PubMed 30223877

Questions about this trial

What is this clinical trial studying?

An observational study of Neoplasms, run by Proton Collaborative Group at 29 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 29 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Define outcomes for patients treated at participating institutions (time frame: PRN). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01255748, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in